Oukang Pharmaceutical announced that the company passed the official on-site inspection by the Austrian Federal Health and Safety Administration in conjunction with the European Medicines Quality Administration, and recently obtained the “Austrian Pharmacovigilance EU Producer GMP Compliance Certificate”, certifying that the active ingredient is diosmin. The certificate shows that the entire production and quality control process of the company's diosmin APIs complies with EU GMP regulatory requirements, has compliance qualifications for supply to EU pharmaceutical companies, and helps expand the European API market.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.